Want to eliminate lung cancer as a cause of death: AstraZeneca India MD

The British drug major is developing next-generation vaccines that have the potential to generate potent and long-lasting immune responses

AstraZeneca is working on several cancer projects in India. The British drug major is also developing next-generation vaccines that have the potential to generate potent and long-lasting immune responses. In an email interview with Sohini Das, AstraZeneca Pharma India Managing Director and Country President Sanjeev Panchal talks about the firm’s plans. Edited excerpts.

What are your projects in lung cancer research? Any project that is undergoing trial in India?

We are focusing on the unmet needs in India and addressing those. To improve outcomes, we are prioritising increasing early screening and diagnosis and addressing the significant unmet need for treatment